861
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Monoclonal antibodies in severe asthma: is it worth it?

ORCID Icon, &
Pages 517-520 | Received 11 Feb 2019, Accepted 17 May 2019, Published online: 23 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Timothy E. Albertson, Janelle V. Pugashetti, Florence Chau-Etchepare, James A. Chenoweth & Susan Murin. (2020) Pharmacotherapeutic management of asthma in the elderly patient. Expert Opinion on Pharmacotherapy 21:16, pages 1991-2010.
Read now

Articles from other publishers (11)

V. V. Naumova, Е. К. Beltyukov, О. P. Kovtun, G. А. Bykova, О. G. Smolenskaya, A. A. Shtanova & D. A. Stepina. (2023) Direct comparative study of the effectiveness of mepolizumab and dupilumab in patients with severe non-allergic eosinophilic asthma. Meditsinskiy sovet = Medical Council.
Crossref
Duong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, Woo-Jung Song, You Sook Cho, Hyunkyoung Kim, Jae-Woo Kwon, So-Young Park, Sujeong Kim, Gyu Young Hur, Byung Keun Kim, Young-Hee Nam, Min-Suk Yang, Mi-Yeong Kim, Sae-Hoon Kim, Byung-Jae Lee, Taehoon Lee, So Young Park, Min-Hye Kim, Young-Joo Cho, ChanSun Park, Jae-Woo Jung, Han Ki Park, Joo-Hee Kim, Ji-Yong Moon, Ian Adcock, Pankaj Bhavsar, Kian Fan Chung & Tae-Bum Kim. (2023) Prospective direct comparison of biologic treatments for severe eosinophilic asthma. Annals of Allergy, Asthma & Immunology.
Crossref
Duong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, Woo-Jung Song, You Sook Cho, Hyunkyoung Kim, Jae-Woo Kwon, So-Young Park, Sujeong Kim, Gyu Young Hur, Byung Keun Kim, Young-Hee Nam, Min-Suk Yang, Mi-Yeong Kim, Sae-Hoon Kim, Byung-Jae Lee, Taehoon Lee, So-Young Park, Min-Hye Kim, Young-Joo Cho, ChanSun Park, Jae-Woo Jung, Han Ki Park, Joo-Hee Kim, Ji-Yong Moon, Pankaj Bhavsar, Ian Adcock, Kian Fan Chung & Tae-Bum Kim. (2023) Prospective direct comparison of biological treatments on severe eosinophilic asthma. Annals of Allergy, Asthma & Immunology.
Crossref
Anne-Noelle Frix, Liam G. Heaney, Barbro Dahlén, Florin Mihaltan, Svetlana Sergejeva, Sanja Popović-Grle, Vratislav Sedlak, Lauri Lehtimäki, Arnaud Bourdin, Stephanie Korn, Eleftherios Zervas, Zsuzsanna Csoma, Dora Lúðvíksdóttir, Marcus Butler, Giorgio Walter Canonica, Ineta Grisle, Kristina Bieksiene, Anneke Ten Brinke, Piotr Kuna, Claudia Chaves Loureiro, Natalia M. Nenasheva, Zorica Lazic, Sabina Škrgat, David Ramos-Barbon, Joerg Leuppi, Bilun Gemicioglu, Apostolos Bossios, Celeste M. Porsbjerg, Elisabeth H. Bel, Ratko Djukanovic & Renaud Louis. (2022) Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study. ERJ Open Research 8:4, pages 00273-2022.
Crossref
Hugo A Farne, Amanda Wilson, Stephen Milan, Emma Banchoff, Freda Yang & Colin VE Powell. (2022) Anti-IL-5 therapies for asthma. Cochrane Database of Systematic Reviews 2022:7.
Crossref
Ariadna Fildan, Ruxandra-Mioara Rajnoveanu, Roxana Cirjaliu, Ionela Pohrib, Emanuela Tudorache, Adrian Ilie, Cristian Oancea & Doina Tofolean. (2021) Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review). Experimental and Therapeutic Medicine 22:5.
Crossref
Said Eduardo Arablin-Oropeza, Víctor González-Uribe, Blanca E. Del Río-Navarro, Ana del Carmen García-González, Elsy M. Navarrete-Rodríguez & Alberto Valencia. (2021) Dupilumab en el tratamiento del asma. Revista Alergia México 67.
Crossref
Armando Partida-Gaytán, Luis Torre-Bouscoulet, Marco Polo Macías, Alejandro Raimondi & Emilio Pizzichini. (2021) Mepolizumab para el tratamiento de asma grave eosinofílica. Revista Alergia México 67.
Crossref
Paola Rogliani, Beatrice Ludovica Ritondo, Josuel Ora, Mario Cazzola & Luigino Calzetta. (2020) SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis. European Respiratory Journal 56:3, pages 2000625.
Crossref
Paola Rogliani, Luigino Calzetta, Maria Gabriella Matera, Rossella Laitano, Beatrice Ludovica Ritondo, Nicola A. Hanania & Mario Cazzola. (2019) Severe Asthma and Biological Therapy: When, Which, and for Whom. Pulmonary Therapy 6:1, pages 47-66.
Crossref
Emma D. Deeks. (2019) Dupilumab: A Review in Moderate to Severe Asthma. Drugs 79:17, pages 1885-1895.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.